- 专利标题： Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors
-
申请号： US15925996申请日： 2018-03-20
-
公开(公告)号： US20180282340A1公开(公告)日： 2018-10-04
- 发明人: Jincong Zhuo , Meizhong Xu , Chunhong He , Colin Zhang , Ding-Quan Qian , David M. Burns , Yun-Long Li , Brian Metcalf , Wenqing Yao
- 申请人： Incyte Corporation , Incyte Holdings Corporation
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/53 ; A61K31/4709 ; C07D403/06
摘要：
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
公开/授权文献
- US10738052B2 Imidazotriaines and imidazopyrimidines as kinase inhibitors 公开/授权日：2020-08-11
信息查询
